What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.19%
Annual Rate
CNY 0.05Paid annual
Payout Ratio
58.8%Sustainable
Last Ex-Dividend
Jul 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.17BCNY
475.18M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
154.94x
Updated Oct 21, 2026
Revenue (TTM)
426.79MCNY
63.97M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
4.86%
Updated Oct 21, 2026
Beta
1.30x
vs all stocks
Updated Oct 21, 2026
52-Week Change
29.75%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
3.17BCNY
475.18M · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
2.68BCNY
401.56M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
154.94x
Updated Oct 21, 2026
Price to Sales (TTM)
7.44x
Updated Oct 21, 2026
Price to Book (MRQ)
2.34x
Updated Oct 21, 2026
Enterprise to Revenue
6.28x
Updated Oct 21, 2026
Enterprise to EBITDA
81.42x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 23.69×.Updated Oct 21, 2026
Gross Margin
52.07%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 39.54%.Updated Oct 21, 2026
Profit Margin
4.86%
Updated Oct 21, 2026
Return on Assets (TTM)
0.35%
Updated Oct 21, 2026
Return on Equity (TTM)
1.34%
Updated Oct 21, 2026
Revenue (TTM)
426.79MCNY
63.97M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
3.70CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
-33.90%
Updated Oct 21, 2026
Gross Profit (TTM)
168.77MCNY
25.30M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
113.07MCNY
16.95M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
20.74MCNY
3.11M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
-47.11%
Updated Oct 21, 2026
Operating Cash Flow (TTM)
53.88MCNY
8.08M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
-8.13MCNY
-1.22M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing Annual Dividend Rate
0.0500CNYUpdated Oct 21, 2026
Trailing Annual Dividend Yield
0.19%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
58.82%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 29.41%.Updated Oct 21, 2026
Minority Interest (Equity)
11.47MCNYFY2025 · Dec 31, 2025
Revenue
463.01MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
276.29MCNYFY2025 · Dec 31, 2025
Gross Profit
186.72MCNYFY2025 · Dec 31, 2025
Operating Income
75.42MCNY
11.30M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
30.84MCNYFY2025 · Dec 31, 2025
Income Tax Expense
653.87KCNYFY2025 · Dec 31, 2025
Net Income
30.19MCNYFY2025 · Dec 31, 2025
EBIT
36.87MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
113.07MCNYFY2025 · Dec 31, 2025
Research & Development
44.35MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
24.45MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
5.21MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
3.10MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
6.03MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.2700CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.2700CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
117.38MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
117.38MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
30.19MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.51MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-30.22MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-61.38MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
612.94MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
30.19MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
6.63MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-135.86MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
68.82MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-31.16MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-5.73BCNYFY2025 · Dec 31, 2025
Sale of Investments
5.80BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
37.85MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
203.15MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-213.85MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-17.38MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-52.15MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-80.24MCNYFY2025 · Dec 31, 2025
Shares Outstanding
120.54MSharesUpdated Oct 21, 2026
Float Shares
57.08MSharesUpdated Oct 21, 2026
% Held by Insiders
49.16%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
3.81%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
556.06MCNY
83.35M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
4.83CNYUpdated Oct 21, 2026
Total Debt (MRQ)
193.09MCNY
28.94M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.1475x
Updated Oct 21, 2026
Current Ratio (MRQ)
5.03x
Updated Oct 21, 2026
Book Value per Share (MRQ)
11.27CNYUpdated Oct 21, 2026
Total Assets
1.74BCNY
260.18M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.35BCNYFY2025 · Dec 31, 2025
Total Liabilities
391.57MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
385.57MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
75.79MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
315.78MCNYFY2025 · Dec 31, 2025
Cash
605.58MCNYFY2025 · Dec 31, 2025
Cash Equivalents
8.98MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
614.56MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
1.17MCNYFY2025 · Dec 31, 2025
Accounts Receivable
556.31MCNYFY2025 · Dec 31, 2025
Inventory
85.34MCNYFY2025 · Dec 31, 2025
Accounts Payable
120.79MCNYFY2025 · Dec 31, 2025
Short-term Debt
118.11MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
3.57MCNYFY2025 · Dec 31, 2025
Long-term Debt
69.75MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
1.15MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
120.54MCNYFY2025 · Dec 31, 2025
Retained Earnings
385.82MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.34BCNY
201.49M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
81.99MCNYFY2025 · Dec 31, 2025
52-Week Low
17.76CNYUpdated Oct 21, 2026
52-Week High
41.65CNYUpdated Oct 21, 2026
52-Week Change
29.75%
vs all stocks
Updated Oct 21, 2026
Beta
1.30x
vs all stocks
Updated Oct 21, 2026
50-Day MA
25.95CNYUpdated Oct 21, 2026
200-Day MA
25.97CNYUpdated Oct 21, 2026
Avg 10-Day Volume
2.76MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
2.87MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
0.1700CNYUpdated Oct 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.52Profit Margin: 0.05
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.70
Altman Z-Score 6.22: safe zoneNotable
Altman Z-Score: 6.22
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Companies that share the same coordination system — how they create, deliver, or capture value.